Literature DB >> 18032062

Therapeutic pathways of adult stem cell repair.

Anthony E Ting1, Robert W Mays, Mark R Frey, Wouter Van't Hof, Satish Medicetty, Robert Deans.   

Abstract

The use of adult stem cells as therapeutic agents to treat disease has become increasingly prevalent. During the last decade, isolated and expanded stem and progenitor cells have demonstrated the capacity to differentiate into multiple cell types. Early optimism that in vitro differentiation capacity would translate into in vivo tissue regeneration has lessened and identifying the mechanisms that underlie the benefit of stem cell repair is an emerging area of investigation. This review considers several of the pathways and mechanisms required for adult stem cell repair. These mechanisms include the mobilization and the homing of stem cells to sites of injury, immunomodulatory effect of stem cells, and the association of stem cells with increased vascularization of injured tissue. These data suggest that the unique properties of adult stem cells can be utilized to treat a wide variety of diseases that cannot be treated with existing pharmacological agents, and prompt new paradigms for the bio-pharmacokinetics of biological expressed by efficacious stem cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18032062     DOI: 10.1016/j.critrevonc.2007.09.007

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN: 1040-8428            Impact factor:   6.312


  10 in total

1.  Adenosine A2A receptors play an active role in mouse bone marrow-derived mesenchymal stem cell development.

Authors:  Majid Katebi; Mansooreh Soleimani; Bruce N Cronstein
Journal:  J Leukoc Biol       Date:  2008-12-12       Impact factor: 4.962

Review 2.  Mesenchymal stem cells for the treatment of neurodegenerative disease.

Authors:  Nanette Joyce; Geralyn Annett; Louisa Wirthlin; Scott Olson; Gerhard Bauer; Jan A Nolta
Journal:  Regen Med       Date:  2010-11       Impact factor: 3.806

3.  Multipotent adult progenitor cells prevent macrophage-mediated axonal dieback and promote regrowth after spinal cord injury.

Authors:  Sarah A Busch; Jason A Hamilton; Kevin P Horn; Fernando X Cuascut; Rochelle Cutrone; Nicholas Lehman; Robert J Deans; Anthony E Ting; Robert W Mays; Jerry Silver
Journal:  J Neurosci       Date:  2011-01-19       Impact factor: 6.167

Review 4.  Regenerative stromal cell therapy in allogeneic hematopoietic stem cell transplantation: current impact and future directions.

Authors:  Jeffery J Auletta; Kenneth R Cooke; Luis A Solchaga; Robert J Deans; Wouter van't Hof
Journal:  Biol Blood Marrow Transplant       Date:  2009-12-16       Impact factor: 5.742

Review 5.  Genetically engineered mesenchymal stem cells as a proposed therapeutic for Huntington's disease.

Authors:  Scott D Olson; Kari Pollock; Amal Kambal; Whitney Cary; Gaela-Marie Mitchell; Jeremy Tempkin; Heather Stewart; Jeannine McGee; Gerhard Bauer; Hyun Sook Kim; Teresa Tempkin; Vicki Wheelock; Geralyn Annett; Gary Dunbar; Jan A Nolta
Journal:  Mol Neurobiol       Date:  2011-12-09       Impact factor: 5.590

6.  Activation of adult mammalian retinal stem cells in vivo via antagonism of BMP and sFRP2.

Authors:  Kenneth N Grisé; Brenda L K Coles; Nelson X Bautista; Derek van der Kooy
Journal:  Stem Cell Res Ther       Date:  2021-10-30       Impact factor: 6.832

7.  Synergistic effect of bone marrow-derived mesenchymal stem cells and platelet-rich plasma in streptozotocin-induced diabetic rats.

Authors:  Zhenzhen Lian; Xiaojing Yin; Hua Li; Lili Jia; Xiuzhen He; Yongbo Yan; Naihua Liu; Kayiu Wan; Xiaokun Li; Shaoqiang Lin
Journal:  Ann Dermatol       Date:  2014-02-17       Impact factor: 1.444

Review 8.  The mammalian blastema: regeneration at our fingertips.

Authors:  Jennifer Simkin; Mimi C Sammarco; Lindsay A Dawson; Paula P Schanes; Ling Yu; Ken Muneoka
Journal:  Regeneration (Oxf)       Date:  2015-06-09

9.  Stromal cell-derived factor-1/CXC chemokine receptor 4 axis in injury repair and renal transplantation.

Authors:  Zejia Sun; Xin Li; Xiang Zheng; Peng Cao; Baozhong Yu; Wei Wang
Journal:  J Int Med Res       Date:  2019-10-03       Impact factor: 1.671

10.  Human multipotent adult progenitor cells effectively reduce graft-vs-host disease while preserving graft-vs-leukemia activity.

Authors:  Leland Metheny; Saada Eid; Patiwet Wuttisarnwattana; Jeffery J Auletta; Chen Liu; Alana Van Dervort; Conner Paez; ZhengHong Lee; David Wilson; Hillard M Lazarus; Robert Deans; Wouter Vant Hof; Yiouli Ktena; Kenneth R Cooke
Journal:  Stem Cells       Date:  2021-07-28       Impact factor: 6.277

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.